SCHEMBL24676321

SCHEMBL24676321

c1ccc2c(c1)oc1ccc3c4ccccc4n(-c4ccc(-c5ccc(-n6c7ccccc7c7ccc8oc9ccccc9c8c76)cc5)cc4)c3c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 5/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
HPGD P15428 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HSD17B10 Q99714 2/20 0.35
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
DUSP3 P51452 1/20 0.35
PTPN5 P54829 1/20 0.35
PTPN11 Q06124 1/20 0.35
HDAC4 P56524 1/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 3/20 0.33
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24676179 1.00 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24174744 0.99 KDM4E (0.43) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24675414 0.99 KDM4E (0.43) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24676095 0.95 KDM4E (0.44) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL17246177 0.94 KDM4E (0.47) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL17246173 0.93 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL17246144 0.93 L3MBTL1 (0.39) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24174202 0.93 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24936735 0.92 L3MBTL1 (0.35) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2
SCHEMBL24676612 0.91 ATM (0.41) KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230033529-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-02 US disclosed
US-20220238815-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2022-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230033529-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, RAP1A KDM4E 3096/4885L3MBTL1 173/4885ATM 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.